ABEONA THERAPEUTICS INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Abeona Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Abeona Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 48.1M shares, a 93.9% increase year-over-year.
  • Abeona Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 21.4M shares, a 172% increase from 2022.
  • Abeona Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 7.86M shares, a 99.6% increase from 2021.
  • Abeona Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 3.94M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 48.1M +23.3M +93.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 40M +22M +122% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 27.3M +10.4M +61.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 21.4M +13.5M +172% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 24.8M +18.4M +286% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 18M +12.2M +210% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 16.9M +11.1M +192% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 7.86M +3.92M +99.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 6.42M +2.5M +63.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 5.81M +1.94M +50.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 5.8M -88.4M -93.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 3.94M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 3.92M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 3.86M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 94.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2014 1.94M +1.44M +285% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 532K +23.6K +4.64% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-14
Q2 2014 26.2M +1.08M +4.3% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 25.9M +1.08M +4.34% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-12
Q4 2013 505K -23.7M -97.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 509K -23.7M -97.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 25.1M +951K +3.94% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 24.8M +655K +2.72% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 24.2M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 24.2M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 24.2M +4.77M +24.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 24.1M +4.9M +25.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q2 2011 19.4M +3.93M +25.4% Apr 2, 2011 Jun 30, 2011 10-Q 2011-08-15
Q1 2011 19.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q2 2010 15.5M Apr 2, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.